Up to now, quality assurance (QA) and quality control (QC) in metabolomics are procedures that most labs did using their own in-house developed procedures and rules since there was no consensus or minimum requirement. Now there is a lot of enthusiasm for developing standardization of QA and QC procedures.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bearden, D. W., Beger, R. D., Broadhurst, D., Dunn, W., Edison, A., Guillou, C., et al. (2014). The New Data Quality Task Group (DQTG): Ensuring high quality data today and in the future. Metabolomics, 10(4), 539.
Beger, R. D., Dunn, W. B., Bandukwala, A., Bethan, B., Broadhurst, D., Clish, C., et al. (2018). Think tank on quality assurance and quality control in untargeted metabolomics studies. Metabolomics. https://doi.org/10.1007/s11306-018-1460-7.
Beger, R. D., Dunn, W., Schmidt, M. A., Gross, S. S., Kirwan, J. A., Cascante, M., et al. (2016). Metabolomics enables precision medicine: “A white paper, community perspective. Metabolomics, 12, 149. https://doi.org/10.1007/s11306-016-1094-6.
Broadhurst, D., Goodacre, R., Reinke, S. N., Kuligowski, J., Wilson, I. D., Lewis, M. R., et al. (2018). Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics, 14, 72. https://doi.org/10.1007/s11306-018-1367-3.
Clayton, T. A., Baker, D., Lindon, J. C., Everrett, J. R., & Nicholson, J. K. (2009). Pharmacometabolomics identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proceedings of the National Academy of Sciences of the United States of America, 106(34), 14728–14733.
Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIn- tyre, S., Anderson, N., et al. (2011). Procedures for large-scale metabolic profile of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols, 6(7), 1060–1083.
Dunn, W. B., Broadhurst, D. I., Edison, A., Guillou, C., Viant, M. R., Bearden, D. W., et al. (2017). Quality assurance and quality control processes: Summary of a metabolomics community questionnaire. Metabolomics, 13(5), 50.
Fiehn, O., Robertson, D., Griffin, J., van der Werf, M., Nikolau, B., Morrison, N., et al. (2007). The metabolomics standards initiative (MSI). Metabolomics, 3, 175–178.
Kaddurah-Daouk, R., Weinshilboum, R. M., & Pharmacometabolomics Research Network. (2014). Pharma-cometabolomics: Implications for clinical pharmacology and systems pharmacology. Clinical Pharmacology and Therapeutics, 95(2), 154–167.
Lewis, M. R., Pearce, J. T., Spagou, K., Green, M., Dona, A. C., Yuen, A. H., et al. (2016). Development and application of ultra-performance liquid chromatorgraphy-TOF MS for precision large scale urinary metabolic phenotyping. Analytical Chemistry, 88(18), 9004–9013.
Sangster, T., Major, H., Plumb, R., Wilson, A. J., & Wilson, I. D. (2006). A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst, 131(10), 1075–1078.
Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., et al. (2006). The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nature Biotechnology, 24(9), 1151–1161.
Shi, L., Perkins, R. G., Fang, H., & Tong, W. (2008). Reproducible and reliable microarray results through quality control: Good laboratory proficiency and appropriate data analysis practices are essential. Current Opinion in Biotechnology, 19(1), 10–18.
Conflict of interest
The author declares that does not have any conflicts of interest.
Research involving human and animal participants
This manuscript does not contain any studies with human participants or animals that performed by the author.
The findings and conclusions in this article have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy.
About this article
Cite this article
Beger, R.D. Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmonization of quality control standards. Metabolomics 15, 1 (2019). https://doi.org/10.1007/s11306-018-1453-6
- Quality control
- Harmonizing QC standards